BlackBerry Limited [BB] vs Amdocs [DOX] Detailed Stock Comparison
BlackBerry Limited
NYSE
Loading...
Amdocs
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: BlackBerry Limited wins in 3 metrics, Amdocs wins in 16 metrics, with 0 ties. Amdocs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | BlackBerry Limited | Amdocs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -33.31 | 17.61 | BlackBerry Limited |
| Price-to-Book Ratio | 3.50 | 2.75 | Amdocs |
| Debt-to-Equity Ratio | 33.20 | 23.65 | Amdocs |
| PEG Ratio | 52.88 | 1.26 | Amdocs |
| EV/EBITDA | 38.15 | 10.36 | Amdocs |
| Profit Margin (TTM) | -14.77% | 11.94% | Amdocs |
| Operating Margin (TTM) | 7.83% | 17.68% | Amdocs |
| EBITDA Margin (TTM) | 7.83% | 17.68% | Amdocs |
| Return on Equity | -1.14% | 15.73% | Amdocs |
| Return on Assets (TTM) | 1.83% | 7.79% | Amdocs |
| Free Cash Flow (TTM) | $6.40M | $618.93M | Amdocs |
| 1-Year Return | 50.83% | 1.38% | BlackBerry Limited |
| Price-to-Sales Ratio (TTM) | 4.74 | 2.08 | Amdocs |
| Enterprise Value | $2.42B | $10.20B | Amdocs |
| EV/Revenue Ratio | 4.53 | 2.20 | Amdocs |
| Gross Profit Margin (TTM) | 73.59% | 37.86% | BlackBerry Limited |
| Revenue per Share (TTM) | $1 | $41 | Amdocs |
| Earnings per Share (Diluted) | $-0.01 | $4.94 | Amdocs |
| Beta (Stock Volatility) | 1.10 | 0.52 | Amdocs |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
BlackBerry Limited vs Amdocs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| BlackBerry Limited | 3.01% | -1.08% | -5.93% | -4.45% | -30.34% | -4.45% |
| Amdocs | 1.92% | -0.85% | -1.61% | -5.57% | -1.58% | 2.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| BlackBerry Limited | 50.83% | -40.07% | -30.21% | -50.47% | -92.06% | -85.81% |
| Amdocs | 1.38% | 0.32% | 42.38% | 50.18% | 228.94% | 204.75% |
Performance & Financial Health Analysis: BlackBerry Limited vs Amdocs
| Metric | BB | DOX |
|---|---|---|
| Market Information | ||
| Market Cap | $2.54B | $9.68B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 13,570,640 | 882,546 |
| 90 Day Avg. Volume | 13,534,030 | 784,365 |
| Last Close | $3.76 | $88.27 |
| 52 Week Range | $2.22 - $6.24 | $78.61 - $95.41 |
| % from 52W High | -39.74% | -7.48% |
| All-Time High | $148.13 (Jun 16, 2008) | $99.75 (Jun 26, 2023) |
| % from All-Time High | -97.46% | -11.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.18% | -0.08% |
| Quarterly Earnings Growth | -0.17% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | -0.15% | 0.12% |
| Operating Margin (TTM) | 0.08% | 0.18% |
| Return on Equity (TTM) | -0.01% | 0.16% |
| Debt to Equity (MRQ) | 33.20 | 23.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.21 | $31.67 |
| Cash per Share (MRQ) | $0.57 | $3.10 |
| Operating Cash Flow (TTM) | $16.50M | $737.18M |
| Levered Free Cash Flow (TTM) | $69.21M | $554.44M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: BlackBerry Limited vs Amdocs
| Metric | BB | DOX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -33.31 | 17.61 |
| Forward P/E | 52.88 | 12.38 |
| PEG Ratio | 52.88 | 1.26 |
| Price to Sales (TTM) | 4.74 | 2.08 |
| Price to Book (MRQ) | 3.50 | 2.75 |
| Market Capitalization | ||
| Market Capitalization | $2.54B | $9.68B |
| Enterprise Value | $2.42B | $10.20B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.53 | 2.20 |
| Enterprise to EBITDA | 38.15 | 10.36 |
| Risk & Other Metrics | ||
| Beta | 1.10 | 0.52 |
| Book Value per Share (MRQ) | $1.21 | $31.67 |
Financial Statements Comparison: BlackBerry Limited vs Amdocs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BB | DOX |
|---|---|---|
| Revenue/Sales | $143.90M | $1.13B |
| Cost of Goods Sold | $38.00M | $698.05M |
| Gross Profit | $105.90M | $430.15M |
| Research & Development | $23.80M | $81.80M |
| Operating Income (EBIT) | $2.10M | $197.74M |
| EBITDA | $11.90M | $244.14M |
| Pre-Tax Income | $-6.50M | $189.27M |
| Income Tax | $1.00M | $25.27M |
| Net Income (Profit) | $-7.00M | $164.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BB | DOX |
|---|---|---|
| Cash & Equivalents | $266.70M | $247.39M |
| Total Current Assets | $591.50M | $1.56B |
| Total Current Liabilities | $344.30M | $1.34B |
| Long-Term Debt | $224.00M | $748.93M |
| Total Shareholders Equity | $719.90M | $3.50B |
| Retained Earnings | $-2.24B | N/A |
| Property, Plant & Equipment | $104.80M | $874.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BB | DOX |
|---|---|---|
| Operating Cash Flow | $42.40M | $195.07M |
| Capital Expenditures | $-100,000 | $-15.96M |
| Free Cash Flow | $40.40M | $156.49M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | $-135.24M |
Short Interest & Institutional Ownership Analysis
| Metric | BB | DOX |
|---|---|---|
| Shares Short | 34.25M | 4.39M |
| Short Ratio | 2.56 | 6.52 |
| Short % of Float | 0.06% | 0.05% |
| Average Daily Volume (10 Day) | 13,570,640 | 882,546 |
| Average Daily Volume (90 Day) | 13,534,030 | 784,365 |
| Shares Outstanding | 596.23M | 112.89M |
| Float Shares | 595.06M | 108.37M |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 0.48% | 0.98% |
Dividend Analysis & Yield Comparison: BlackBerry Limited vs Amdocs
| Metric | BB | DOX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |